Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -202620252024202320222021202020192018201720162015 3 November 2020 Biocartis and GeneproDx To Collaborate on Fully Automated ThyroidPrint® test on Idylla™ Non-regulated information 29 October 2020 Biocartis and Exact Sciences Agree to End Collaboration Due to Changed Market Circumstances Inside information Regulated information 29 October 2020 Update on the Partnership with Exact Sciences Inside information Regulated information 6 October 2020 Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™ Non-regulated information 1 October 2020 CORPORATE STATEMENT: Biocartis Joins COVID-19 Testing Industry Consortium of Nineteen Healthcare Community Organizations Non-regulated information 30 September 2020 Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay Non-regulated information 25 September 2020 Results of the Extraordinary Shareholders’ Meeting held on 25 September 2020 Regulated information 14 September 2020 Large Prospective Lung Cancer Study To Be Presented at ESMO Congress Shows Idylla™ Reduces EGFR Mutation Testing Turnaround Time by More than a Week Non-regulated information 4 September 2020 Invitation to the Extraordinary Shareholders’ Meeting Regulated information 3 September 2020 Biocartis announces H1 2020 results Regulated information Pagination First page « First Previous page ‹‹ … Page 10 Page 11 Page 12 Page 13 Current page 14 Page 15 Page 16 Page 17 Page 18 … Next page ›› Last page Last »